Funding Rounds
VectorY

VectorY Series A (2023, $137M)

VectorY

Antibody therapeutics treatment for neurodegenerative diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $137.72M

Investors